Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Coartem, artemether/lumefantrine
print preview
bookmark
share with colleague
General Information
Company
Novartis AG
Description
Fixed-dose artemisinin-based combination treatment
Molecular Target
Mechanism of Action
Latest Stage of Development
Marketed
Indication
Malaria
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information